Follow
István Bitter
István Bitter
Semmelweis University
Verified email at semmelweis.hu
Title
Cited by
Cited by
Year
Genome-wide association study identifies five new schizophrenia loci
Nature genetics 43 (10), 969-976, 2011
20122011
Prevalence and correlates of adult attention-deficit hyperactivity disorder: meta-analysis
V Simon, P Czobor, S Bálint, A Mészáros, I Bitter
The British Journal of Psychiatry 194 (3), 204-211, 2009
19852009
Common variants conferring risk of schizophrenia
H Stefansson, RA Ophoff, S Steinberg, OA Andreassen, S Cichon, ...
Nature 460 (7256), 744-747, 2009
19362009
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders, part 1: update 2013 on the acute and …
M Bauer, A Pfennig, E Severus, PC Whybrow, J Angst, HJ Möller, ...
The world journal of biological psychiatry 14 (5), 334-385, 2013
6092013
Updated European Consensus Statement on diagnosis and treatment of adult ADHD
JJS Kooij, D Bijlenga, L Salerno, R Jaeschke, I Bitter, J Balazs, J Thome, ...
European psychiatry 56 (1), 14-34, 2019
6052019
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders, part 1: acute and continuation treatment of …
M Bauer, PC Whybrow, J Angst, M Versiani, HJ Möller, ...
The World Journal of Biological Psychiatry 3 (1), 5-43, 2002
5232002
The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2012 on the long-term treatment of …
H Grunze, E Vieta, GM Goodwin, C Bowden, RW Licht, HJ Möller, ...
The World Journal of Biological Psychiatry 14 (3), 154-219, 2013
5012013
Efficacy of esketamine nasal spray plus oral antidepressant treatment for relapse prevention in patients with treatment-resistant depression: a randomized clinical trial
EJ Daly, MH Trivedi, A Janik, H Li, Y Zhang, X Li, R Lane, P Lim, AR Duca, ...
JAMA psychiatry 76 (9), 893-903, 2019
4692019
Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo-and paroxetine-controlled trial
MJ Detke, CG Wiltse, CH Mallinckrodt, RK McNamara, MA Demitrack, ...
European Neuropsychopharmacology 14 (6), 457-470, 2004
3972004
Cariprazine versus risperidone monotherapy for treatment of predominant negative symptoms in patients with schizophrenia: a randomised, double-blind, controlled trial
G Németh, I Laszlovszky, P Czobor, E Szalai, B Szatmári, J Harsányi, ...
The Lancet 389 (10074), 1103-1113, 2017
3842017
Stratified medicine for mental disorders
G Schumann, EB Binder, A Holte, ER de Kloet, KJ Oedegaard, ...
European Neuropsychopharmacology 24 (1), 5-50, 2014
2752014
Mortality in people with schizophrenia: a systematic review and meta‐analysis of relative risk and aggravating or attenuating factors
CU Correll, M Solmi, G Croatto, LK Schneider, SC Rohani‐Montez, ...
World Psychiatry 21 (2), 248-271, 2022
2712022
Common variants at VRK2 and TCF4 conferring risk of schizophrenia
S Steinberg, S de Jong, OA Andreassen, T Werge, AD Břrglum, O Mors, ...
Human molecular genetics 20 (20), 4076-4081, 2011
2512011
Attention deficit hyperactivity disorder (ADHD): gender-and age-related differences in neurocognition
S Bálint, P Czobor, S Komlósi, A Meszaros, V Simon, I Bitter
Psychological medicine 39 (8), 1337-1345, 2009
2312009
Persistent negative symptoms in first episode patients with schizophrenia: results from the European First Episode Schizophrenia Trial
S Galderisi, A Mucci, I Bitter, J Libiger, P Bucci, WW Fleischhacker, ...
European Neuropsychopharmacology 23 (3), 196-204, 2013
2182013
Mental health research priorities for Europe
T Wykes, JM Haro, SR Belli, C Obradors-Tarragó, C Arango, ...
The Lancet Psychiatry 2 (11), 1036-1042, 2015
2162015
The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders, part III: maintenance treatment
H Grunze, S Kasper, G Goodwin, C Bowden, H Mo¨ ller, ...
The World Journal of Biological Psychiatry 5 (3), 120-135, 2004
1992004
Genetic Risk and Outcome in Psychosis (GROUP). Common variants conferring risk of schizophrenia
H Stefansson, RA Ophoff, S Steinberg, OA Andreassen, S Cichon, ...
Nature 460 (7256), 744-747, 2009
1972009
Expanding the range of ZNF804A variants conferring risk of psychosis
S Steinberg, O Mors, AD Břrglum, O Gustafsson, T Werge, PB Mortensen, ...
Molecular psychiatry 16 (1), 59-66, 2011
1822011
A blind spot on the global mental health map: a scoping review of 25 years' development of mental health care for people with severe mental illnesses in central and eastern Europe
P Winkler, D Krupchanka, T Roberts, L Kondratova, V Machů, C Höschl, ...
The Lancet Psychiatry 4 (8), 634-642, 2017
1682017
The system can't perform the operation now. Try again later.
Articles 1–20